Immunovant Inc — Quarterly Financial Statistics (NASDAQ:IMVT) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities 100.39 M110.64 M117.41 M102.52 M92.33 M 422.89 M Cash from investing activities 180 K201 K000 201 K Cash from financing activities 2.46 M450.61 M2.92 M24.59 M564.6 M 1.04 B Free cash flow 100.21 M110.44 M117.41 M102.52 M92.33 M 422.69 M

Nouvelles

Immunovant stock hits 52-week high at 28.32 USD

Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards?

Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?

Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?

IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus

L’action d’Immunovant atteint un niveau record à 27,87 USD

Immunovant stock hits all-time high at 27.87 USD

Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript

Roivant Sciences T4 2025 : les données positives de brepocitinib stimulent l’élan du pipeline

Les actions d’Immunovant bondissent de 7% alors que la perte au T3 se réduit

Immunovant shares jump 7% as Q3 loss narrows, beats estimates

Philip Morris, Biogen, Telenor, and more set to report earnings Friday